CMS Clarifies Factors It Will Consider In Negotiating Drug Prices

By Gabrielle Wanneh / September 8, 2023 at 7:28 PM
A new fact sheet released by CMS Friday (Sept. 8) offers more insight into how Medicare’s first round of price negotiations for expensive Medicare Part D drugs will run, coming as drug maker agreements to participate in the program are due Oct. 1. CMS is inviting stakeholders to submit any data related to factors such as therapeutic alternatives to the drugs selected for negotiation , how the selected drugs address unmet medical needs and the impact of selected drugs on...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.